Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2024 · 62 positions · Total reported value $2.64B · Top-10 concentration 52.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2024 13F filing, Deep Track Capital, LP disclosed 62 equity positions with a combined reported value of $2.64B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were DVAX ($227.20M), GH ($196.12M), ITCI ($167.04M). By sector, the heaviest allocations are Health Care 65.7%, Other 34.3%. Versus the prior quarter, allocation shifted toward Other (+6.8pp) and away from Health Care (-6.8pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 56% of names.

The largest new positions opened in Q4 2024 were HRMY ($49.89M), SEPN ($43.81M), GMAB ($41.74M).

Of the 15 positions fully exited versus the prior quarter, the largest were ARGX ($197.86M), NTLA ($101.72M), ALKS ($97.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • HRMY HARMONY BIOSCIENCES HLDGS IN · $49.89M
  • SEPN SEPTERNA INC · $43.81M
  • GMAB GENMAB A/S · $41.74M
  • CLDX CELLDEX THERAPEUTICS INC NEW · $38.92M
  • PTGX PROTAGONIST THERAPEUTICS INC · $38.60M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $27.49M
  • BBIO BRIDGEBIO PHARMA INC · $22.48M
  • LKFT LAKEFRONT BIOTHERAPEUTICS NV · $21.47M

Fully Exited (vs previous quarter)

  • ARGX ARGENX SE · prev qtr: $197.86M
  • NTLA INTELLIA THERAPEUTICS INC · prev qtr: $101.72M
  • ALKS ALKERMES PLC · prev qtr: $97.97M · history
  • APGE APOGEE THERAPEUTICS INC · prev qtr: $58.74M
  • TGTX TG THERAPEUTICS · prev qtr: $40.35M
  • KURA KURA ONCOLOGY INC · prev qtr: $38.37M
  • KYMR KYMERA THERAPEUTICS INC · prev qtr: $28.41M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $21.82M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 65.7%
Other 34.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 17.79M $227.20M 8.61%
8.61%
Add
2 6.42M $196.12M 7.43%
7.43%
Add
3 2.00M $167.04M 6.33%
6.33%
Add
4 6.00M $148.62M 5.63%
5.63%
Add
5 4.27M $136.41M 5.17%
5.17%
Reduce
6 3.46M $125.04M 4.74%
4.74%
Reduce
7 2.50M $117.60M 4.46%
4.46%
Add
8 12.84M $109.62M 4.15%
4.15%
Add
9 4.52M $86.70M 3.29%
3.29%
Add
10 5.97M $78.65M 2.98%
2.98%
Hold
11 2.80M $75.94M 2.88%
2.88%
Add
12 1.93M $67.61M 2.56%
2.56%
Reduce
13 3.00M $56.52M 2.14%
2.14%
Reduce
14 3.02M $55.64M 2.11%
2.11%
Hold
15 6.48M $50.66M 1.92%
1.92%
Add
16 1.45M $49.89M 1.89%
1.89%
New
17 2.00M $47.12M 1.79%
1.79%
Reduce
18 1.91M $43.81M 1.66%
1.66%
New
19 2.00M $41.74M 1.58%
1.58%
New
20 1.49M $41.45M 1.57%
1.57%
Add
21 850.00K $39.47M 1.50%
1.50%
Reduce
22 1.54M $38.92M 1.48%
1.48%
New
23 1.00M $38.60M 1.46%
1.46%
New
24 649.04K $35.88M 1.36%
1.36%
Add
25 2.00M $34.84M 1.32%
1.32%
Add
26 14.22M $33.41M 1.27%
1.27%
Reduce
27 874.61K $33.30M 1.26%
1.26%
Add
28 5.58M $30.89M 1.17%
1.17%
Hold
29 4.56M $30.31M 1.15%
1.15%
Add
30 653.51K $27.49M 1.04%
1.04%
New
31 3.58M $26.20M 0.99%
0.99%
Hold
32 1.35M $22.61M 0.86%
0.86%
Hold
33 819.16K $22.48M 0.85%
0.85%
New
34 780.78K $21.47M 0.81%
0.81%
New
35 3.44M $20.07M 0.76%
0.76%
Reduce
36 2.82M $19.60M 0.74%
0.74%
Reduce
37 710.42K $18.97M 0.72%
0.72%
Reduce
38 1.28M $17.87M 0.68%
0.68%
Reduce
39 1.00M $16.44M 0.62%
0.62%
New
40 2.00M $16.08M 0.61%
0.61%
New
41 519.38K $15.32M 0.58%
0.58%
New
42 750.00K $14.54M 0.55%
0.55%
Reduce
43 4.01M $14.20M 0.54%
0.54%
Reduce
44 1.53M $13.49M 0.51%
0.51%
Hold
45 1.19M $12.61M 0.48%
0.48%
Add
46 500.00K $11.49M 0.43%
0.43%
Reduce
47 244.11K $9.73M 0.37%
0.37%
Hold
48 6.01M $9.50M 0.36%
0.36%
New
49 3.28M $8.21M 0.31%
0.31%
Hold
50 7.42M $7.79M 0.29%
0.29%
Hold

FAQ

What did Deep Track Capital, LP buy in 2024-Q4?

In its 2024-Q4 13F filing, Deep Track Capital, LP reported 62 equity positions worth $2.64B in aggregate; its largest disclosed positions were DVAX ($227.20M), GH ($196.12M), ITCI ($167.04M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $2.64B of long equity holdings across 62 positions as of 2024-Q4. Top-10 holdings account for 52.8% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →